American Association for Clinical Chemistry
Better health through laboratory medicine
2009 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

09/23/09 AACC joined with other health care groups in writing to House and Senate legislators in support of maintaining AHRQ as the lead federal agency overseeing comparative effectiveness research.
   
09/15/09 AACC provided input to CMS regarding its preliminary payment determinations for the clinical laboratory fee schedule
   
09/14/09  AACC wrote to Senator Max Baucus (D-MT) expressing its opposition to a proposed $750 million tax on clinical laboratories
   
09/08/09 AACC provided comments to AHRQ regarding its draft Technology Assessment on laboratory developed molecular tests
   
08/13/09 AACC wrote to Senator Edward Kennedy (D-MA) urging that evolving health care reform legislation maintain AHRQ’s leading role in comparative effectiveness research
   
07/31/09  The Clinical Laboratory Coalition wrote to Senate Max Baucus (D-MT) opposing the establishment of a Medicare co-payment for clinical laboratory tests
   
07/08/09  AACC wrote to Rep. David Obey (D-WI) urging continued federal funding for the NIH National Children’s Study
   
07/08/09  AACC wrote to Senator Max Baucus (D-MT) expressing support for S.1213, the Patient-Centered Outcomes Research Act of 2009, which would provide additional funding for comparative effectiveness research
   
5/08/09 AACC submitted comments to SACHGS in regards to its draft report on gene patients and licensing
   
5/07/09 AACC joined with the Clinical Laboratory Coalition in identifying joint principles for health care reform
 
5/06/09 AACC wrote to HHS Secretary Sebelius urging stimulus funds be set aside to assist medical technology training programs
 
5/06/09 AACC wrote to the White House and congressional leaders identifying  key principles for health care reform
 
4/29/09 AACC joined with other laboratory groups in writing HHS Secretary Sebelius in support of personalized medicine
 
4/13/09 AACC wrote to the HHS Federal Coordinating Council for Comparative Effectiveness Research recommending priority research areas
 
4/13/09 AACC wrote AHRQ recommending priority areas for comparative effectiveness research
 
3/19/09 AACC, as part of the Friends of AHRQ Coalition, wrote congressional leaders in support of higher AHRQ funding for health care research
 
02/24/09 AACC wrote to Speaker of the House Nancy Pelosi in support of funding for the NIH National Children’s Study and AHRQ comparative effective program included in the 2009 Omnibus Appropriations Bill
 
02/19/09 AACC wrote to key Committee Chairs in support of funding for the NIH National Children’s Study and AHRQ comparative effective program included in the 2009 Omnibus Appropriations Bill
 
02/19/09 AACC provided comments to Medicare contractor, National Government Services, in regards to its draft Local Coverage Determination (LCD) for Vitamin D assay testing (DL29510)
   
01/27/09 AACC wrote to key House and Senate leaders in support of the comparative effectiveness and health IT provisions in the American Recovery and Reinvestment Plan 
   
01/16/09 AACC Position on Reporting and Use of Estimated Average Glucose in Diabetes